Xcout Intel
Transcripta Bio
Transcripta Bio is a biotechnology company headquartered in Palo Alto, California, that maps cellular responses to diseases to discover and identify therapeutic molecules.
Subscribe to see Transcripta Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Transcripta Bio at a glance
Transcripta Bio is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $24M in July 2026. Xcout tracks 8 named people at Transcripta Bio, including Clayton Mellina (CTO).
Transcripta Bio leadership
- Clayton MellinaCTO
- Chris Moxhamco-founder, CEO, and Chief Scientific Officer
- Deanna WongVP of People & Operations
- Nicole PerfitoVP of Program Management
- Ciaran O'LearyBoard Member
- John LeeBoard Member
2 more named people on record for Transcripta Bio, with roles, board committees and tenure — see the full roster →
Transcripta Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $24M | 4 named | |
| Seed | $2.6M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Transcripta Bio competitors
A few of Transcripta Bio's closest competitors — see the full list of competitors and alternatives →
Sculpta Bio is a biotechnology research company headquartered in San Francisco, California, known as the Protein Sculpting Company.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Arda Therapeutics is a TechBio therapeutics company focused on accelerating pathobiology-driven therapeutic development. The company is headquartered in the San Francisco Bay Area.
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Octant Bio is a biotechnology company that combines next-generation biology, chemistry, and computation to discover and develop precision small molecule therapeutics. The company targets complex cellular mechanisms to address genetic diseases, such as protein misfolding and mistrafficking across various therapeutic areas including genetic disorders, oncology, metabolism, and immunology.
Get Transcripta Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Transcripta Bio in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access